Fares Noujaim, an executive vice chairman at Bank of America has left the company abruptly.» Read More
NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AbbVie rose 2.5 percent to $56.95 with 17,522,600 shares traded. Bank of America Corp. fell 1.3 percent to $16.14 with 77,241,800 shares traded.
Baxter International Inc. rose$. 12 or. 2 percent, to $74.34. Bristol-Myers Squibb Co. fell$. 46 or. 9 percent, to $50.73. Hospira rose$. 29 or. 6 percent, to $53.01.
Baxter International Inc. rose$. 04 or. 1 percent, to $74.26. Bristol-Myers Squibb Co. fell$. 47 or. 9 percent, to $50.72. Hospira rose$. 01 or percent, to $52.73.
Baxter International Inc. rose$. 02 or percent, to $74.22. Bristol-Myers Squibb Co. rose$. 07 or. 1 percent, to $51.19. Hospira fell $1.18 or 2.2 percent, to $52.72.
NEW YORK, Sept 8- Mathew Martoma, a former portfolio manager at billionaire Steven A. Cohen's SAC Capital Advisors LP hedge fund, was sentenced on Monday to nine years in prison for engaging in what authorities called the most lucrative insider trading scheme in U.S. history. District Judge Paul Gardephe in New York also ordered Martoma, 40, to forfeit $9.3 million.
Baxter International Inc. rose$. 40 or. 5 percent, to $74.60. Bristol-Myers Squibb Co. fell$. 01 or percent, to $51.11. Hospira fell$. 88 or 1.6 percent, to $53.02.
NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Bank of America Corp. rose 2.1 percent to $16.35 with 92,087,900 shares traded. Boston Scientific Corp. rose 2.6 percent to $12.32 with 33,048,900 shares traded.
NEW YORK— An Ivy League- educated ex-portfolio manager convicted of enabling his firm to earn more than a quarter-billion dollars through insider trading on a promising Alzheimer's drug trial was sentenced Monday to nine years in prison by a judge who said the "staggering" fraud deserved lengthy incarceration.
Baxter International Inc. rose$. 06 or. 1 percent, to $74.26. Bristol-Myers Squibb Co. rose$. 02 or percent, to $51.14. Hospira fell $1.22 or 2.3 percent, to $52.68.
NEW YORK, Sept 4- A federal judge on Thursday refused to throw out the insider trading conviction of former SAC Capital portfolio manager Mathew Martoma, saying the trial evidence "overwhelmingly demonstrated Martoma's guilt."
*Zoetis explores international markets for product. CHICAGO, Sept 3- Zoetis Inc has received a conditional license from the U.S. Department of Agriculture for its vaccine against a deadly piglet virus and will begin selling it this month in the United States, the company said on Wednesday.
CHICAGO, Sept 3- Zoetis Inc, the world's largest animal-health company, has received a conditional license from the U.S. Agriculture Department for its vaccine against a deadly piglet virus and will begin selling it this month in the United States, the company said on Wednesday.
Some of Tuesday's midday movers:
*Bid target AstraZeneca falls; CEO says "back to normal". LONDON, Sept 2- A fall in major healthcare stocks, after drugmaker AstraZeneca tried to play down speculation about a new bid from Pfizer, pegged back European stock markets on Tuesday. "We wouldn't chase stocks at these levels," said HED Capital head Richard Edwards.
Dollar General sweetens Family Dollar bid, may go hostile. Dollar General Corp raises its bid for Family Dollar Stores Inc to $9.1 billion, and warns it may turn hostile and appeal directly to shareholders if the new offer is rejected.
*Bid target AstraZeneca falls; CEO says "back to normal". LONDON, Sept 2- European shares slipped on Tuesday as major healthcare stocks fell after drugmaker AstraZeneca tried to play down speculation about a new bid from Pfizer. A 1.8 percent fall at AstraZeneca took the most points off the index.
BARCELONA, Sept 2- Though speculation is rife of a new Pfizer bid, AstraZeneca's chief executive is not holed up with advisers in London or New York. Strict British takeover rules limit what Soriot and other players can say about Pfizer's abortive attempt to buy AstraZeneca and the possibility of a resumption of talks.
Public pension funds have major stakes in American firms moving overseas to cut their tax bills. But they are saying little about the strategy.
*Novartis's LCZ696 and PCSK9 drugs could treat millions. Hopes have spiked for a heart failure drug from Novartis and an innovative class of injectable anti-cholesterol agents known as PCSK9 inhibitors after the release of data at the ESC's annual meeting indicated that they can save more lives than standard therapies.
*Sanofi, Regeneron vying with drugs from Amgen and Pfizer. BARCELONA, Aug 31- An experimental cholesterol-lowering drug from Sanofi and Regeneron Pharmaceuticals roughly halved the number of heart attacks and strokes in a clinical trial, researchers reported on Sunday.